Analysis of CD8+ T lymphocyte-mediated nonlytic suppression of autologous and heterologous primary human immunodeficiency virus type 1 isolates

AIDS Research and Human Retroviruses

Volumn 13, Issue 8, 1997, Pages 685-693

  Kootstra, Neeltje A ^a   Miedema, Frank ^a   Schuitemaker, Hanneke ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS ISOLATION;

EID: 0030914740     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.685     Document Type: Article

References (48)

1. Tersmette M, Gruters RA, De Wolf F, et al.: Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: Studies on sequential HIV isolates. J Virol 1989;63:2118-2125.
2. Asjo B, Albert J, Karlsson A, et al.: Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986;ii:660-662.
3. Nair MPN, Pottathil R, Heimer EP, and Schwartz SA: Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: Effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc Natl Acad Sci USA 1988;85:6498-6502.
4. Evans LA, McHugh TM, Stites DP, and Levy JA: Differential ability of HIV isolates to productively infect human cells. J Immunol 1987;138:3415-3418.
5. Schuitemaker H, Koot M, Kootstra NA, et al.: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992;66:1354-1360.
6. Koot M, Van't Wout AB, Kootstra NA, De Goede REY, Tersmette M, and Schuitemaker H: Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J Infect Dis 1996;173:349-354.
7. Connor RI, Mohri H, Cao Y, and Ho DD: Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1 infected individuals. J Virol 1993;67:1772-1777.
8. + cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-688.
9. Cao Y, Qin L, Zhang L, Safrit JT, and Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332: 201-208.
10. Schellekens PThA, Roos MThL, De Wolf F, Lange JMA, and Miedema F: Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for AIDS in HIV-1 infected men. J Clin Immunol 1990;10:121-127.
11. Roos MThL, Miedema F, Koot M, et al.: T-cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus (HIV)-infected asymptomatic individuals. J Infect Dis 1995;171:531-536.
12. Meltzer MS, Skillman DR, Hoover DL, et al.: Macrophages and the human immunodeficiency virus. Immunol Today 1990;11:217-223.
13. Gartner S, Markovits P, Markovits DM, Kaplan MH, Gallo RC, and Popovic M: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986;233:215-219.
14. Embretson J, Zupancic M, Ribas JL, et al.: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-361.
15. Schuitemaker H, Kootstra NA, De Goede REY, De Wolf F, Miedema F, and Tersmette M: Monocytotropic human immunodeficiency virus 1 (HIV-1) variants detectable in all stages of HIV infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol 1991;65:356-363.
16. Bozzette SA, McCutchan JA, Spector SA, Wright B, and Richman DD: A cross-sectional comparison of persons with syncytium- and non-syncytium inducing human immunodeficiency virus. J Infect Dis 1993;168:1374-1379.
17. Hoffenbach A, Langlade-Demoyen P, Dadaglio G, et al.: Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 1989;142:452-462.
18. Carmichael A, Jin X, Sissons P, and Borysiewicz L: Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993;177:249-256.
19. Klein MR, Van Baalen CA, Holwerda AM, et al.: Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-1372.
20. Brinchmann JE, Gaudernack G, and Vartal F: CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. J Immunol 1990;144:2961-2966.
21. Mackewicz CE, Ortega HW, and Levy JA: CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991;87:1462-1466.
22. Landay AL, Mackewicz CE, and Levy JA: An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol 1993;69:106-116.
23. Gomez AM, Smaill FM, and Rosenthal KL: Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease. Clin Exp Immunol 1994;97:68-75.
24. Barker E, Mackewicz CE, and Levy JA: Effect of Th1 and Th2 cytokines on CD8+ cell response against human immunodeficiency virus: Implications for long-term survival. Proc Natl Acad Sci USA 1995;92:11135-11139.
25. Reinherz EL, Penta AC, Hussey RE, and Schlossman SF: A rapid method for separating functionally intact human T lymphocytes with monoclonal antibodies. Clin Immunol Immunopathol 1981; 21:257-266.
26. Tersmette M, Winkel IN, Groenink M, et al.: Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV-p24gag. Virology 1989;171:149-155.
27. Koot M, Vos AHV, Keet RPM, et al.: HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 1992;6:49-54.
28. Kinter AL, Bende SM, Hardy EC, Jackson R, and Fauci AS: Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression. Proc Natl Acad Sci USA 1995;92:10985-10989.
29. Racadot E, Schaal JP, Van Lemmens P, Billot M, and Herve P: Immunological characteristics of umbilical cord blood cells: Phenotypic and functional analysis. J Hematother 1993;2:251-253.
30. Rabian-Herzog C, Lesage S, Gluckman E, and Charron D: Characterization of lymphocyte subpopulations in cord blood. J Hematother 1993;2:255-257.
31. Bruisten SM, Koppelman MHGM, Dekker JT, et al.: Concordance of human immunodificiency virus detection by polymerase chain reaction and by serologic assays in a dutch cohort of seroneative homosexual men. J Infect Dis 1992;166:620-622.
32. Ferbas J, Kaplan AH, Hausner MA, et al.: Virus burden in long-term survivors of HIV infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis 1995;172:329-339.
33. + cells varies among infected individuals. Cell Immunol 1989;119:470-475.
34. Copeland KFT, Leith J, Kelleher L, Smaill F, and Rosenthal KL: CD8 T lymphocyte-mediated suppression of HIV-1 LTR-mediated transcription shows no correlation with clinical stage of disease of health status. XIth Int. Conf. on AIDS 1996. [Abstract]
35. Schuitemaker H, Kootstra NA, Fouchier RAM, Hooibrink B, and Miedema F: Productive HIV-1 infection of macrophages restricted to the cell fraction with proliferative capacity. EMBO J 1994;13: 5929-5936.
36. Walker CM, Erickson AL, Hsueh FC, and Levy JP: Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism. J Virol 1991;65:5921-5927.
37. Ennen J, Findeklee H, Dittmar MT, Norley S, Ernst M, and Kurth R: CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc Natl Acad Sci USA 1994;91:7207-7211.
38. Walker CM, Moody DJ, Stites DP, and Levy JA: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-1566.
39. Wiviott LD, Walker CM, and Levy JA: CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells. Cell Immunol 1990;128:628-634.
40. Chen C, Weinhold KJ, Bartlett JA, Bolognesi DP, and Greenberg ML: CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: A novel antiviral mechanism. AIDS Res Hum Retroviruses 1993;9:1079-1086.
41. Mackewicz CE, Blackbourn DJ, and Levy JA: CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA 1995;92:2308-2312.
42. Copeland KFT, McKay PJ, and Rosenthal KL: Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific. AIDS Res Hum Retroviruses 1995;11:1321-1326.
43. Baier M, Werner A, Bannert N, Metzner K, and Kurth R: HIV suppression by interleukin-16. Nature (London) 1995;378:563.
44. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso P: Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
45. Alkhatib G, Combadiere C, Broder CC, et al.: CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
46. Deng HK, Liu R, Ellmeier W, et al.: Identification of the major co-receptor for primary isolates of HIV-1. Nature (London) 1996; 381:661-666.
47. Dragic T, Litwin V, Allaway GP, et al.: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 1996;381:667-673.
48. Mackewicz CE, Barker E, and Levy JA: Role of β-chemokines in suppressing HIV replication. Science 1996;274:1393-1394.